Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
Eppinga RN, Hartman MH, van Veldhuisen DJ, Lexis CP, Connelly MA, Lipsic E, van der Horst IC, van der Harst P, Dullaart RP. Eppinga RN, et al. Among authors: dullaart rp. PLoS One. 2016 Jan 25;11(1):e0145719. doi: 10.1371/journal.pone.0145719. eCollection 2016. PLoS One. 2016. PMID: 26808474 Free PMC article. Clinical Trial.
Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.
Kappelle PJ, Dallinga-Thie GM, Dullaart RP; Diabetes Atorvastatin Lipid Intervention (DALI) study group. Kappelle PJ, et al. Among authors: dullaart rp. Biochim Biophys Acta. 2010 Jan;1801(1):89-94. doi: 10.1016/j.bbalip.2009.09.021. Epub 2009 Oct 2. Biochim Biophys Acta. 2010. PMID: 19800983 Clinical Trial.
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.
Sofat R, Hingorani AD, Smeeth L, Humphries SE, Talmud PJ, Cooper J, Shah T, Sandhu MS, Ricketts SL, Boekholdt SM, Wareham N, Khaw KT, Kumari M, Kivimaki M, Marmot M, Asselbergs FW, van der Harst P, Dullaart RP, Navis G, van Veldhuisen DJ, Van Gilst WH, Thompson JF, McCaskie P, Palmer LJ, Arca M, Quagliarini F, Gaudio C, Cambien F, Nicaud V, Poirer O, Gudnason V, Isaacs A, Witteman JC, van Duijn CM, Pencina M, Vasan RS, D'Agostino RB Sr, Ordovas J, Li TY, Kakko S, Kauma H, Savolainen MJ, Kesäniemi YA, Sandhofer A, Paulweber B, Sorli JV, Goto A, Yokoyama S, Okumura K, Horne BD, Packard C, Freeman D, Ford I, Sattar N, McCormack V, Lawlor DA, Ebrahim S, Smith GD, Kastelein JJ, Deanfield J, Casas JP. Sofat R, et al. Among authors: dullaart rp. Circulation. 2010 Jan 5;121(1):52-62. doi: 10.1161/CIRCULATIONAHA.109.865444. Epub 2009 Dec 21. Circulation. 2010. PMID: 20026784 Free PMC article.
Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.
Constantinides A, van Pelt LJ, van Leeuwen JJ, de Vries R, Tio RA, van der Horst IC, Sluiter WJ, Dullaart RP. Constantinides A, et al. Among authors: dullaart rp. Eur J Clin Invest. 2011 Aug;41(8):820-7. doi: 10.1111/j.1365-2362.2011.02471.x. Epub 2011 Jan 31. Eur J Clin Invest. 2011. PMID: 21281278
Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels.
Li N, van der Sijde MR; LifeLines Cohort Study Group; Bakker SJ, Dullaart RP, van der Harst P, Gansevoort RT, Elbers CC, Wijmenga C, Snieder H, Hofker MH, Fu J. Li N, et al. Among authors: dullaart rp. Diabetes. 2014 Sep;63(9):3149-58. doi: 10.2337/db13-1800. Epub 2014 Apr 10. Diabetes. 2014. PMID: 24722249
496 results